Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FNNMC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,848
Award facts
- Contract value 100% obligated
- $17,848.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,848.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors. This non-competitive delivery order, with an ultimate completion date of October 22, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, with demonstrated capability to fulfill open competition requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This delivery order for Dupixent, a biologic immunosuppressant used to treat conditions including atopic dermatitis and eosinophilic asthma, reflects ongoing federal procurement of specialized pharmaceutical treatments to support military healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB26FNNMC?
SPE2DB26FNNMC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FNNMC worth?
The government has obligated $17,848 on SPE2DB26FNNMC.
Is contract SPE2DB26FNNMC an order under another contract?
Yes. SPE2DB26FNNMC is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB26FNNMC competed?
The extent of competition for SPE2DB26FNNMC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award